AN2 Therapeutics said it was planning to meet with the U.S. Food and Drug Administration to discuss a development path for epetraborole, a treatment of non-tuberculous mycobacterial lung disease. The ...

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its ...

AN2 Therapeutics, Inc. ( (ANTX)) has shared an announcement. AN2 Therapeutics has promoted its Chief Legal Counsel, Joshua Eizen, to the roles of Chief Legal Officer and Chief Operating Officer, ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mineralys Therapeutics, Inc. (MLYS – ...

If ultimately fully funded, the MPC2SC Program will start by identifying 10 students at the community college during their ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

MENLO PARK, Calif. - AN2 Therapeutics, Inc. (NASDAQ:ANTX), a biopharmaceutical company specializing in boron-based small molecule therapeutics, has announced the extension of a research grant from the ...

Tech-enabled sleep health company Nox Health was the highest bidder for Pear Therapeutics' Somryst assets at an auction last month that followed the prescription digital therapeutic company's ...

Today, we revisit Bicycle Therapeutics plc, a clinical-stage biopharma firm, that has intriguing potential and focuses on developing medicines for unmet needs. The company is advancing several ...